Navigation Links
NCCN Holds Oncology Research Best Practices Conference
Date:9/14/2009

NCCN is holding the NCCN Oncology Research Best Practices Conference(TM), an interactive forum to discuss the regulatory and operational aspects of research and help identify areas in the clinical trial process where improvements can be made. Scheduled for October 26 - 27 in Bethesda, MD, the conference will include lectures, interactive workshops, and panel discussions on topics that challenge the conduct of oncology research as well as topics related to ethical considerations.

FORT WASHINGTON, Pa., Sept. 14 /PRNewswire-USNewswire/ -- Significant strides in the prevention, detection, and treatment of cancer have been made possible through clinical trials, however regulatory and ethical issues can pose challenges to clinical investigators. The National Comprehensive Cancer Network (NCCN), an alliance of 21 of the world's leading cancer centers, is drawing on its collective expertise and holding the NCCN Oncology Research Best Practices Conference(TM) to review and discuss regulatory and operational aspects of research and help identify areas in the clinical trial process where improvements can be made.

The two-day conference being held October 26 - 27 in Bethesda, MD, will include lectures, interactive workshops, and panel discussions with audience participation on topics that challenge the conduct of oncology research as well as topics related to ethical considerations and maintaining and improving regulatory compliance. Attendees will learn about innovative practices and organizational structures that work and new ideas and perspectives that will lead to increased productivity and quality.

The conference is designed to be interactive and meet the needs of a multidisciplinary audience including oncology researchers, research nurses, Institutional Review Board (IRB) professionals, research administrators, academics, ethicists, government regulators, and industry sponsors on best practices in oncology research.

NCCN recognizes the importance of investing in clinical trials, which can result in changes in the standard of care and improved patient outcomes. Through the NCCN Oncology Research Program (ORP), more than $20 million of funding has been obtained to support investigator-initiated trials at NCCN Member Institutions to explore new avenues of clinical investigation and answer important scientific questions. The NCCN ORP recently launched a new platform, the Drug Development Research Grant Model that provides a mechanism for research on drugs in early stages of development.

Complete program details and online registration for the NCCN Oncology Research Best Practices Conference(TM) are available at NCCN.org.

About the National Comprehensive Cancer Network

The National Comprehensive Cancer Network (NCCN), a not-for-profit alliance of 21 of the world's leading cancer centers, is dedicated to improving the quality and effectiveness of care provided to patients with cancer. Through the leadership and expertise of clinical professionals at NCCN Member Institutions, NCCN develops resources that present valuable information to the numerous stakeholders in the health care delivery system. As the arbiter of high-quality cancer care, NCCN promotes the importance of continuous quality improvement and recognizes the significance of creating clinical practice guidelines appropriate for use by patients, clinicians, and other health care decision-makers. The primary goal of all NCCN initiatives is to improve the quality, effectiveness, and efficiency of oncology practice so patients can live better lives.

The NCCN Member Institutions are: City of Hope Comprehensive Cancer Center, Los Angeles, CA; Dana-Farber/Brigham and Women's Cancer Center / Massachusetts General Hospital Cancer Center, Boston, MA; Duke Comprehensive Cancer Center, Durham, NC; Fox Chase Cancer Center, Philadelphia, PA; Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT; Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance, Seattle, WA; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD; Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL; Memorial Sloan-Kettering Cancer Center, New York, NY; H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL; The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute, Columbus, OH; Roswell Park Cancer Institute, Buffalo, NY; Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine, St. Louis, MO; St. Jude Children's Research Hospital/University of Tennessee Cancer Institute, Memphis, TN; Stanford Comprehensive Cancer Center, Stanford, CA; University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, AL; UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; University of Michigan Comprehensive Cancer Center, Ann Arbor, MI; UNMC Eppley Cancer Center at The Nebraska Medical Center, Omaha, NE; The University of Texas M. D. Anderson Cancer Center, Houston, TX; and Vanderbilt-Ingram Cancer Center, Nashville, TN.

For more information on NCCN, please visit NCCN.org.


'/>"/>
SOURCE National Comprehensive Cancer Network
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Blue Cross and Blue Shield Association Holds Forum to Explore Patient Safety and Healthcare Quality Initiatives
2. Fauquier Health System Holds a Food Show with a Twist Long Term Care Patients Hold the Judges Pen as Vendors Vie for Approval
3. Discovery of widespread tumor growth gene holds promise for effective anti-cancer treatment
4. Epilepsy Drug Holds Promise as Treatment for Alcoholism
5. Sunday, October 14, MSPP holds Sixth Annual Lucero Memorial Run and Latino Leadership Breakfast
6. Alzheimers Foundation of America Holds Fifth Annual National Memory Screening Day
7. European Patent Office Upholds Verathons IP Against Aircraft Medical Challenge
8. University Hospitals Case Medical Center finds new treatment holds promise for Tourette syndrome
9. Go Red For Women Holds Nationwide Casting Call to Find the Heart of Go Red
10. Fruit fly phlebotomy holds neuroscience promise
11. American Association for Dental Research holds 37th annual meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... ... of Bruton Memorial Library on June 21 due to a possible lice infestation, as reported ... head lice: the parasite’s ability to live away from a human host, and to infest ... in the event that lice have simply gotten out of control. , As lice are ...
(Date:6/25/2016)... ... June 25, 2016 , ... On Friday, June 10, ... Bronze Wellness at Work award to iHire in recognition of their exemplary accomplishments in ... the 7th annual Maryland Workplace Health & Wellness Symposium at the BWI Marriott in ...
(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... Marcy was in a crisis. Her ... would lash out at his family verbally and physically. , “When something upset him, he ... he would use it. He would throw rocks at my other children and say he ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and ... that call for a minimum wage raise to $12 an hour by 2020 and then ... will restore the lost value of the minimum wage, assure the wage floor does not ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... feeding the Frederick area economy by obtaining investment capital for emerging technology companies. ... 2½ years that have already resulted in more than a million dollars of ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 2016   Pulmatrix, Inc ., (NASDAQ: ... drugs, announced today that it was added to the ... its comprehensive set of U.S. and global equity indexes ... important milestone for Pulmatrix," said Chief Executive Officer ... our progress in developing drugs for crucial unmet medical ...
(Date:6/24/2016)... , June 24, 2016  Arkis BioSciences, ... less invasive and more durable cerebrospinal fluid treatments, ... funding.  The Series-A funding is led by Innova ... Fund, and other private investors.  Arkis, new financing ... instrumentation and the market release of its in-licensed ...
(Date:6/23/2016)... 23, 2016 Research and Markets has ... - Forecast to 2022" report to their offering. ... for the patients with kidney failure, it replaces the function ... the patient,s blood and thus the treatment helps to keep ... in balance. Increasing number of ESRD patients ...
Breaking Medicine Technology: